Search scope:
排序: Display mode:
Yunfeng Fu, Xinyu Wang, Zimin Pan, Xing Xie
Frontiers of Medicine 2014, Volume 8, Issue 1, Pages 91-95 doi: 10.1007/s11684-014-0305-7
Keywords: ovarian carcinoma prognostic factors surgery chemotherapy survival
Wen Xue,Yan Sheng,Xiangqin Weng,Yongmei Zhu,Yan Zhao,Pengpeng Xu,Xiaochun Fei,Xiaoyan Chen,Li Wang,Weili Zhao
Frontiers of Medicine 2015, Volume 9, Issue 4, Pages 468-477 doi: 10.1007/s11684-015-0419-6
Keywords: mature T-cell lymphoid malignancies clonal T-cell population bone marrow infiltration prognostic factors
Yinjun Lou, Yafang Ma, Chenyin Li, Sansan Suo, Hongyan Tong, Wenbin Qian, Wenyuan Mai, Haitao Meng, Wenjuan Yu, Liping Mao, Juyin Wei, Weilei Xu, Jie Jin
Frontiers of Medicine 2017, Volume 11, Issue 2, Pages 229-238 doi: 10.1007/s11684-017-0506-y
A CALLG2008 protocol was developed by the Chinese Acute Lymphoblastic Leukemia Cooperative Group for adult acute lymphoblastic leukemia (ALL). We retrospectively analyzed 153 newly diagnosed adult patients with Philadelphia chromosome (Ph)-positive ALL enrolled into imatinib (400 mg/d) plus CALLG2008 regimen between 2009 and 2015. The median age was 40 years (range, 18–68 years), with 81 (52.3%) males. The overall hematologic complete remission (CR) rate was 96.7% after induction. With a median follow-up of 24.2 months, the estimated 3-year overall survival (OS) and event-free survival (EFS) rates were 49.5% (95% confidence interval (CI): 38.5%–59.5%) and 49.2% (95% CI: 38.3%–59.2%), respectively. Fifty-eight (36 with haploidentical donor) patients underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) in first CR. Among the patients in CR1 after induction, both the 3-year OS and EFS were significantly better in the allo-HSCT group than in the without allo-HSCT group (73.2%, 95% CI: 58.3%–83.5% vs. 22.2%, 95% CI: 8.7%–39.6% and 66.5%, 95% CI: 50.7%–78.2% vs. 16.1%, 95% CI: 5.1%–32.7%, respectively). Multivariate analysis showed that allo-HSCT and achievement of major molecular response were associated with favorable OS or EFS independently. Interestingly, in the allo-HSCT cohort, the donor type (haploidentical versus matched donors) had no significant impact on EFS or OS. All these results suggested that imatinib plus CALLG2008 was an effective protocol for Ph-positive ALL. Haploidentical donors can also be a reasonable alternative expedient donor pool.
Keywords: Philadelphia chromosome acute lymphoblastic leukemia imatinib CALLG2008
Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis
Shang-Long LIU, Zi-Fang SONG, Qing-Gang HU, Shao-Bo HU, Jun LI, Qi-Chang ZHENG, Duo SHAN,
Frontiers of Medicine 2010, Volume 4, Issue 4, Pages 457-462 doi: 10.1007/s11684-010-0240-1
Keywords: cholangiocarcinoma prognostic factors serum carbohydrate antigen 19-9
Frontiers of Medicine 2021, Volume 15, Issue 6, Pages 942-942 doi: 10.1007/s11684-021-0876-z
A review of condition-based maintenance: Its prognostic and operational aspects
Yanrong LI, Shizhe PENG, Yanting LI, Wei JIANG
Frontiers of Engineering Management 2020, Volume 7, Issue 3, Pages 323-334 doi: 10.1007/s42524-020-0121-5
Keywords: condition-based maintenance prognostics operational decision-making reliability
Four-protein model for predicting prognostic risk of lung cancer
Frontiers of Medicine 2022, Volume 16, Issue 4, Pages 618-626 doi: 10.1007/s11684-021-0867-0
Keywords: lung cancer HSP90β decision tree model prognosis
Lan Wang,Jueheng Wu,Jie Yuan,Xun Zhu,Hongmei Wu,Mengfeng Li
Frontiers of Medicine 2016, Volume 10, Issue 1, Pages 41-51 doi: 10.1007/s11684-016-0429-z
Keywords: breast cancer MID2 proliferation overall survival xenograft
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 685-698 doi: 10.1007/s11684-022-0942-1
Keywords: acute myeloid leukemia acyl-CoA synthetase long chain family member 5 Wnt3a palmitoylation ABT-199
Qiong DAI MD, Bei LIU MD, Yukai DU MM,
Frontiers of Medicine 2009, Volume 3, Issue 4, Pages 452-458 doi: 10.1007/s11684-009-0080-z
Keywords: meta-analysis breast cancer risk factors reproductive factors oral contraceptive use
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era
Haiyan He, Yang Shen, Yongmei Zhu, Saijuan Chen
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 204-211 doi: 10.1007/s11684-012-0202-x
Keywords: imatinib chronic myeloid leukemia complete cytogenetic response
Risk factors of prognosis after acute kidney injury in hospitalized patients
Sasa Nie, Zhe Feng, Lihua Xia, Jiuxu Bai, Fenglin Xiao, Jian Liu, Li Tang, Xiangmei Chen
Frontiers of Medicine 2017, Volume 11, Issue 3, Pages 393-402 doi: 10.1007/s11684-017-0532-9
The risk factors, especially laboratory indicators, of prognosis after acute kidney injury (AKI) remainThe epidemiological features and factors influencing hospital mortality and renal function recovery wereIncreased AKI stage, tumor disease, post-cardiopulmonary resuscitation, and RRT were the risk factorsIn addition to traditional risk factors, white blood cell count, platelet count, albumin, and BMI wereNo laboratory indicators were found to be the risk factors of renal function recovery in AKI patients
Keywords: acute kidney injury risk factors prognosis
Yiwen Cao, Zhenhua Liu, Wen Wu, Ying Qian, Qin Shi, Rong Shen, Binshen Ouyang, Pengpeng Xu, Shu Cheng, Jin Ye, Yiming Lu, Chaofu Wang, Chengde Yang, Li Wang, Weili Zhao
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 94-103 doi: 10.1007/s11684-019-0680-1
Keywords: immunologic marker diffuse large B-cell lymphoma prognosis
Factors affecting the distribution of microplastics in soils of China
Frontiers of Environmental Science & Engineering 2023, Volume 17, Issue 9, doi: 10.1007/s11783-023-1710-4
● Microplastic (MP) abundance in soil of China was highly heterogeneous.
Keywords: Microplastic distribution Microplastic heterogeneity Effecting factors Agriculture Socio-economicfactors
Epidemic obesity in children and adolescents: risk factors and prevention
Eun Young Lee, Kun-Ho Yoon
Frontiers of Medicine 2018, Volume 12, Issue 6, Pages 658-666 doi: 10.1007/s11684-018-0640-1
Keywords: obesity children adolescents epidemiology risk factor prevention
Title Author Date Type Operation
Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line
Yunfeng Fu, Xinyu Wang, Zimin Pan, Xing Xie
Journal Article
Clinical characteristics and prognostic factors of patients with mature T-cell lymphoid malignancies:
Wen Xue,Yan Sheng,Xiangqin Weng,Yongmei Zhu,Yan Zhao,Pengpeng Xu,Xiaochun Fei,Xiaoyan Chen,Li Wang,Weili Zhao
Journal Article
Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed
Yinjun Lou, Yafang Ma, Chenyin Li, Sansan Suo, Hongyan Tong, Wenbin Qian, Wenyuan Mai, Haitao Meng, Wenjuan Yu, Liping Mao, Juyin Wei, Weilei Xu, Jie Jin
Journal Article
Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis
Shang-Long LIU, Zi-Fang SONG, Qing-Gang HU, Shao-Bo HU, Jun LI, Qi-Chang ZHENG, Duo SHAN,
Journal Article
Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer
Journal Article
A review of condition-based maintenance: Its prognostic and operational aspects
Yanrong LI, Shizhe PENG, Yanting LI, Wei JIANG
Journal Article
Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer
Lan Wang,Jueheng Wu,Jie Yuan,Xun Zhu,Hongmei Wu,Mengfeng Li
Journal Article
ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/-catenin signaling
Journal Article
Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive
Qiong DAI MD, Bei LIU MD, Yukai DU MM,
Journal Article
Prognostic analysis of chronic myeloid leukemia in Chinese population in an imatinib era
Haiyan He, Yang Shen, Yongmei Zhu, Saijuan Chen
Journal Article
Risk factors of prognosis after acute kidney injury in hospitalized patients
Sasa Nie, Zhe Feng, Lihua Xia, Jiuxu Bai, Fenglin Xiao, Jian Liu, Li Tang, Xiangmei Chen
Journal Article
Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large
Yiwen Cao, Zhenhua Liu, Wen Wu, Ying Qian, Qin Shi, Rong Shen, Binshen Ouyang, Pengpeng Xu, Shu Cheng, Jin Ye, Yiming Lu, Chaofu Wang, Chengde Yang, Li Wang, Weili Zhao
Journal Article